{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:54:19Z","timestamp":1765356859457,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIDA"},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Merck Pharmaceuticals"},{"DOI":"10.13039\/100000125","name":"NIOSH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000125","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Viral hepatitis leads to immune-mediated liver injury. The rate of disease progression varies between individuals. We aimed to phenotype immune cells associated with preservation of normal liver function during hepatitis C virus (HCV) infection. Clinical data and specimens were obtained from 19 HCV-infected patients undergoing liver transplantation. Liver and peripheral blood mononuclear cells were isolated and eight subsets of innate immune cells were delineated by multiparameter flow cytometry. Cytokine assays and microarrays were performed. Intrahepatic CD56<jats:sup>Bright<\/jats:sup>\/CD16<jats:sup>-<\/jats:sup>natural killer (NK) cells comprised the only subset correlating with better liver function, i.e., lower bilirubin (<jats:italic>p<\/jats:italic>\u2009=\u20090.0002) and lower model for end stage of liver disease scores (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). The signature of liver NK cells from HCV-infected patients included genes expressed by NK cells in normal liver and by decidual NK cells. Portal vein blood had a higher concentration of interleukin (IL)-10 than peripheral blood (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). LMCs were less responsive to toll-like receptor (TLR) stimulation than PBMCs, with fewer pro-inflammatory gene-expression pathways up-regulated after in vitro exposure to lipopolysaccharide and a TLR-7\/8 agonist. Hepatic CD56<jats:sup>Bright<\/jats:sup>\/CD16<jats:sup>-<\/jats:sup>NK cells may be critical for maintaining liver homeostasis. Portal vein IL-10 may prime inhibitory pathways, attenuating TLR signaling and reducing responsiveness to pro-inflammatory stimuli.<\/jats:p>","DOI":"10.1038\/s41598-020-80819-8","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T11:02:30Z","timestamp":1610708550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A subset of liver resident natural killer cells is expanded in hepatitis C-infected patients with better liver function"],"prefix":"10.1038","volume":"11","author":[{"given":"Erin H.","family":"Doyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costica","family":"Aloman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"El-Shamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeeb","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arielle L.","family":"Klepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandy","family":"Haydel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander S.","family":"Florman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Isabel","family":"Fiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea D.","family":"Branch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"80819_CR1","doi-asserted-by":"crossref","unstructured":"Asrani, S.K. et al. Increasing health care burden of chronic liver disease compared with other chronic diseases, 2004\u20132013. Gastroenterology 155, 719\u2013729 e714 (2018).","DOI":"10.1053\/j.gastro.2018.05.032"},{"key":"80819_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri981","volume":"3","author":"IN Crispe","year":"2003","unstructured":"Crispe, I. N. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3, 51\u201362 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"80819_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.gastro.2010.10.059","volume":"140","author":"A Sanchez-Fueyo","year":"2011","unstructured":"Sanchez-Fueyo, A. & Strom, T. B. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology 140, 51\u201364 (2011).","journal-title":"Gastroenterology"},{"key":"80819_CR4","doi-asserted-by":"publisher","first-page":"e1007935","DOI":"10.1371\/journal.ppat.1007935","volume":"15","author":"EH Doyle","year":"2019","unstructured":"Doyle, E. H. et al. Individual liver plasmacytoid dendritic cells are capable of producing IFNalpha and multiple additional cytokines during chronic HCV infection. PLoS Pathog. 15, e1007935 (2019).","journal-title":"PLoS Pathog."},{"key":"80819_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","volume":"572","author":"N Aizarani","year":"2019","unstructured":"Aizarani, N. et al. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 572, 199\u2013204 (2019).","journal-title":"Nature"},{"key":"80819_CR6","unstructured":"Organization, W.H. Global Health Estimates 2016: Disease burden by Cause, Age, Sex, by Country and by Region, 2000\u20132016. (2018)."},{"key":"80819_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jhep.2009.10.016","volume":"52","author":"AW Lohse","year":"2010","unstructured":"Lohse, A. W., Weiler-Normann, C. & Tiegs, G. Immune-mediated liver injury. J. Hepatol. 52, 136\u2013144 (2010).","journal-title":"J. Hepatol."},{"key":"80819_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1479-5876-10-158","volume":"10","author":"AL Zignego","year":"2012","unstructured":"Zignego, A. L., Giannini, C., Gragnani, L., Piluso, A. & Fognani, E. Hepatitis C virus infection in the immunocompromised host: A complex scenario with variable clinical impact. J. Transl. Med. 10, 158 (2012).","journal-title":"J. Transl. Med."},{"key":"80819_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/COH.0b013e32834bd365","volume":"6","author":"MD Hernandez","year":"2011","unstructured":"Hernandez, M. D. & Sherman, K. E. HIV\/hepatitis C coinfection natural history and disease progression. Curr. Opin. HIV AIDS 6, 478\u2013482 (2011).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"80819_CR10","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1053\/jlts.2003.50250","volume":"9","author":"J Neuberger","year":"2003","unstructured":"Neuberger, J. Treatment of hepatitis C virus infection in the allograft. Liver Transpl. 9, S101-108 (2003).","journal-title":"Liver Transpl."},{"key":"80819_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/hep.25723","volume":"56","author":"S Varchetta","year":"2012","unstructured":"Varchetta, S. et al. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection. Hepatology 56, 841\u2013849 (2012).","journal-title":"Hepatology"},{"key":"80819_CR12","doi-asserted-by":"publisher","first-page":"e105950","DOI":"10.1371\/journal.pone.0105950","volume":"9","author":"C Cosgrove","year":"2014","unstructured":"Cosgrove, C. et al. Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver. PLoS ONE 9, e105950 (2014).","journal-title":"PLoS ONE"},{"key":"80819_CR13","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1053\/j.gastro.2013.01.021","volume":"144","author":"Y Hoshida","year":"2013","unstructured":"Hoshida, Y. et al. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology 144, 1024\u20131030 (2013).","journal-title":"Gastroenterology"},{"key":"80819_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaut.2015.08.011","volume":"66","author":"K Hudspeth","year":"2016","unstructured":"Hudspeth, K. et al. Human liver-resident CD56(bright)\/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J. Autoimmun. 66, 40\u201350 (2016).","journal-title":"J. Autoimmun."},{"key":"80819_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.2789","volume":"15","author":"S Li","year":"2014","unstructured":"Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15, 195\u2013204 (2014).","journal-title":"Nat. Immunol."},{"key":"80819_CR16","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","volume":"10","author":"D Pende","year":"2019","unstructured":"Pende, D. et al. Killer Ig-like receptors (KIRs): Their role in NK cell modulation and developments leading to their clinical exploitation. Front. Immunol. 10, 1179 (2019).","journal-title":"Front. Immunol."},{"key":"80819_CR17","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1038\/s41598-017-03256-0","volume":"7","author":"DSJ Allan","year":"2017","unstructured":"Allan, D. S. J. et al. Transcriptome analysis reveals similarities between human blood CD3(-) CD56(bright) cells and mouse CD127(+) innate lymphoid cells. Sci. Rep. 7, 3501 (2017).","journal-title":"Sci. Rep."},{"key":"80819_CR18","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/eji.201646559","volume":"46","author":"C Harmon","year":"2016","unstructured":"Harmon, C. et al. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver. Eur. J. Immunol. 46, 2111\u20132120 (2016).","journal-title":"Eur. J. Immunol."},{"key":"80819_CR19","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1002\/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K","volume":"32","author":"J Pardo","year":"2002","unstructured":"Pardo, J., Balkow, S., Anel, A. & Simon, M. M. Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control. Eur. J. Immunol. 32, 2881\u20132887 (2002).","journal-title":"Eur. J. Immunol."},{"key":"80819_CR20","doi-asserted-by":"publisher","first-page":"2148129","DOI":"10.1155\/2016\/2148129","volume":"2016","author":"MB Khawar","year":"2016","unstructured":"Khawar, M. B., Azam, F., Sheikh, N. & Abdul Mujeeb, K. How does interleukin-22 mediate liver regeneration and prevent injury and fibrosis?. J. Immunol. Res. 2016, 2148129 (2016).","journal-title":"J. Immunol. Res."},{"key":"80819_CR21","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/hep.20184","volume":"39","author":"S Radaeva","year":"2004","unstructured":"Radaeva, S., Sun, R., Pan, H. N., Hong, F. & Gao, B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39, 1332\u20131342 (2004).","journal-title":"Hepatology"},{"key":"80819_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/hep.24339","volume":"54","author":"O Park","year":"2011","unstructured":"Park, O. et al. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology 54, 252\u2013261 (2011).","journal-title":"Hepatology"},{"key":"80819_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/j.gastro.2007.09.034","volume":"134","author":"WI Jeong","year":"2008","unstructured":"Jeong, W. I., Park, O. & Gao, B. Abrogation of the antifibrotic effects of natural killer cells\/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134, 248\u2013258 (2008).","journal-title":"Gastroenterology"},{"key":"80819_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2011.01.001","volume":"22","author":"CJ Horras","year":"2011","unstructured":"Horras, C. J., Lamb, C. L. & Mitchell, K. A. Regulation of hepatocyte fate by interferon-\u03b3. Cytokine Growth Factor Rev. 22, 35\u201343 (2011).","journal-title":"Cytokine Growth Factor Rev."},{"key":"80819_CR25","doi-asserted-by":"crossref","unstructured":"Tan-Garcia, A. et al. Intrahepatic CD206+ macrophages contribute to inflammation in advanced viral-related liver disease. J. Hepatol. (2017).","DOI":"10.1016\/j.jhep.2017.04.023"},{"key":"80819_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"issue":"Suppl A","key":"80819_CR27","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.placenta.2006.01.009","volume":"27","author":"J Tabiasco","year":"2006","unstructured":"Tabiasco, J. et al. Human decidual NK cells: Unique phenotype and functional properties\u2014A review. Placenta 27(Suppl A), S34-39 (2006).","journal-title":"Placenta"},{"key":"80819_CR28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20030305","volume":"198","author":"LA Koopman","year":"2003","unstructured":"Koopman, L. A. et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198, 1201\u20131212 (2003).","journal-title":"J. Exp. Med."},{"key":"80819_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/ncb867","volume":"4","author":"H Hanafusa","year":"2002","unstructured":"Hanafusa, H., Torii, S., Yasunaga, T. & Nishida, E. Sprouty1 and Sprouty2 provide a control mechanism for the Ras\/MAPK signalling pathway. Nat. Cell Biol. 4, 850\u2013858 (2002).","journal-title":"Nat. Cell Biol."},{"key":"80819_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.22950","volume":"50","author":"KR Karlmark","year":"2009","unstructured":"Karlmark, K. R. et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50, 261\u2013274 (2009).","journal-title":"Hepatology"},{"key":"80819_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri, M. A. Human natural killer cells. Blood 112, 461\u2013469 (2008).","journal-title":"Blood"},{"key":"80819_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00005-013-0258-6","volume":"62","author":"I Mozer-Lisewska","year":"2014","unstructured":"Mozer-Lisewska, I. et al. Detection and significance of cytotoxic cell subsets in biopsies of HCV-infected human livers. Arch. Immunol. Ther. Exp. 62, 153\u2013160 (2014).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"80819_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1034\/j.1600-0528.2002.017416.x","volume":"174","author":"DG Doherty","year":"2000","unstructured":"Doherty, D. G. & O\u2019Farrelly, C. Innate and adaptive lymphoid cells in the human liver. Immunol. Rev. 174, 5\u201320 (2000).","journal-title":"Immunol. Rev."},{"key":"80819_CR34","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.4049\/jimmunol.163.4.2314","volume":"163","author":"DG Doherty","year":"1999","unstructured":"Doherty, D. G. et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol. 163, 2314\u20132321 (1999).","journal-title":"J. Immunol."},{"key":"80819_CR35","doi-asserted-by":"publisher","first-page":"26157","DOI":"10.1038\/srep26157","volume":"6","author":"KA Stegmann","year":"2016","unstructured":"Stegmann, K. A. et al. CXCR6 marks a novel subset of T-bet(lo)Eomes(hi) natural killer cells residing in human liver. Sci. Rep. 6, 26157 (2016).","journal-title":"Sci. Rep."},{"key":"80819_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nat. Immunol. 9, 503\u2013510 (2008).","journal-title":"Nat. Immunol."},{"key":"80819_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/imr.12151","volume":"258","author":"H Wang","year":"2014","unstructured":"Wang, H. & Yang, Y. G. The complex and central role of interferon-gamma in graft-versus-host disease and graft-versus-tumor activity. Immunol. Rev. 258, 30\u201344 (2014).","journal-title":"Immunol. Rev."},{"key":"80819_CR38","doi-asserted-by":"crossref","unstructured":"Feng, D. et al. Interleukin-22 promotes proliferation of liver stem\/progenitor cells in mice and patients with chronic hepatitis B virus infection. Gastroenterology 143, 188\u2013198 e187 (2012).","DOI":"10.1053\/j.gastro.2012.03.044"},{"key":"80819_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","volume":"45","author":"A Melhem","year":"2006","unstructured":"Melhem, A. et al. Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J. Hepatol. 45, 60\u201371 (2006).","journal-title":"J. Hepatol."},{"key":"80819_CR40","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.4049\/jimmunol.174.4.2037","volume":"174","author":"A De Creus","year":"2005","unstructured":"De Creus, A. et al. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J. Immunol. 174, 2037\u20132045 (2005).","journal-title":"J. Immunol."},{"key":"80819_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jhep.2009.04.026","volume":"51","author":"Y Chen","year":"2009","unstructured":"Chen, Y. et al. Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J. Hepatol. 51, 510\u2013519 (2009).","journal-title":"J. Hepatol."},{"key":"80819_CR42","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2008-05-159921","volume":"112","author":"S Xia","year":"2008","unstructured":"Xia, S. et al. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood 112, 3175\u20133185 (2008).","journal-title":"Blood"},{"key":"80819_CR43","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.4049\/jimmunol.172.2.1009","volume":"172","author":"VG Pillarisetty","year":"2004","unstructured":"Pillarisetty, V. G., Shah, A. B., Miller, G., Bleier, J. I. & DeMatteo, R. P. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J. Immunol. 172, 1009\u20131017 (2004).","journal-title":"J. Immunol."},{"key":"80819_CR44","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.4049\/jimmunol.0901362","volume":"184","author":"MG Lassen","year":"2010","unstructured":"Lassen, M. G., Lukens, J. R., Dolina, J. S., Brown, M. G. & Hahn, Y. S. Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state. J. Immunol. 184, 2693\u20132701 (2010).","journal-title":"J. Immunol."},{"key":"80819_CR45","doi-asserted-by":"crossref","unstructured":"Bohne, F. et al. HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans. Sci. Transl. Med. 6, 242ra281 (2014).","DOI":"10.1126\/scitranslmed.3008793"},{"key":"80819_CR46","doi-asserted-by":"crossref","unstructured":"Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500\u2013501 (2006).","DOI":"10.1038\/ng0506-500"},{"key":"80819_CR47","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353\u2013D361 (2017).","journal-title":"Nucleic Acids Res."},{"key":"80819_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","volume":"18","author":"A Fabregat","year":"2017","unstructured":"Fabregat, A. et al. Reactome pathway analysis: A high-performance in-memory approach. BMC Bioinform. 18, 142 (2017).","journal-title":"BMC Bioinform."},{"key":"80819_CR49","unstructured":"Broad Institute. 3.2 Why does GSEA use a false discovery rate (FDR) of 0.25 rather than the more classic 0.05? http:\/\/software.broadinstitute.org\/cancer\/software\/gsea\/wiki\/index.php\/FAQ#Why_does_GSEA_use_a_false_discovery_rate_.28FDR.29_of_0.25_rather_than_the_more_classic_0.05.3F. Accessed 3 Oct 2020 (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80819-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80819-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80819-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T20:16:20Z","timestamp":1697573780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80819-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80819"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80819-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"11 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1551"}}